Bio-Connect
IHC-P analysis of mouse thymus (Right panel shows staining without primary antibody as negative control) using GTX89752 FOXP3 antibody, C-term. Antigen retrieval : Tris/EDTA buffer pH 9 Dilution : 2microg/ml
IHC-P analysis of mouse thymus (Right panel shows staining without primary antibody as negative control) using GTX89752 FOXP3 antibody, C-term. Antigen retrieval : Tris/EDTA buffer pH 9 Dilution : 2microg/ml
IHC-P analysis of mouse thymus (Right panel shows staining without primary antibody as negative control) using GTX89752 FOXP3 antibody, C-term. Antigen retrieval : Tris/EDTA buffer pH 9 Dilution : 2microg/ml

FOXP3 antibody, C-term

GTX89752
GeneTex
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityMouse
TargetFoxp3
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    FOXP3 antibody, C-term
  • Delivery Days Customer
    7
  • Application Supplier Note
    IHC-P: 2-4microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.50 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID20371
  • Target name
    Foxp3
  • Target description
    forkhead box P3
  • Target synonyms
    forkhead box protein P3; JM2; scu; scurfin; scurfy; sf
  • Host
    Goat
  • Isotype
    IgG
  • Protein IDQ99JB6
  • Protein Name
    Forkhead box protein P3
  • Scientific Description
    The protein encoded by this gene is a member of the forkhead/winged-helix family of transcriptional regulators. Defects in this gene result in the scurfy phenotype (sf). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
  • Reactivity
    Mouse
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
    Read more